Concepedia

Yongxu Li

YL

3

Publications

78

Citations

3

H-Index

2020

Active since

Affiliations

China Pharmaceutical University(Current)

State Key Laboratory of Natural Medicine

Yongxu Li is an author at China Pharmaceutical University specializing in tumor biology, cancer research, and medicine.

ORCID

Top concepts

Publications per year

2020–2022

3

Publications

3

TRAF4 Maintains Deubiquitination of Caveolin-1 to Drive Glioblastoma Stemness and Temozolomide Resistance

Yongxu Li, Tiepeng Wang, Quan Wan et al. · Cancer Research · 2022 · 40 citations

CRMP2 is a therapeutic target that suppresses the aggressiveness of breast cancer cells by stabilizing RECK

Binyan Lin, Yongxu Li, Tiepeng Wang et al. · Oncogene · 2020 · 20 citations

, , +8

A novel kinase inhibitor, LZT-106, downregulates Mcl-1 and sensitizes colorectal cancer cells to BH3 mimetic ABT-199 by targeting CDK9 and GSK-3β signaling

Zhou Yu, Jiaying Du, Yue Zhao et al. · Cancer Letters · 2020 · 18 citations

, , +10

Rows per page

1–3 of 3